TG Therapeutics (TGTX)
NASDAQ:TGTX
Holding TGTX?
Track your performance easily

TG Therapeutics (TGTX) Ownership - Who Owns TG Therapeutics?

1,700 Followers

TG Therapeutics (TGTX) Ownership Overview

31.91%17.73%30.64%19.72%
31.91% Insiders
30.64% Other Institutional Investors
― ETFs
19.72% Public Companies and Individual Investors
The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. , 31.91% is owned by Insiders, and 19.72% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 20, 2024
Sagar Lonial
Director
xxxxxxxxxxxxx
$432889
Mar 15, 2024
Sagar Lonial
Director
xxxxxxxxxxxxx
$79650
Mar 13, 2024
xxxxxxxxxxxxx
$351340
Jan 08, 2024
xxxxxxxxxxxxx
$333025

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$1079372
Jun 30, 2024
xxxxxxxxxxxxx
$1304131
Jun 30, 2024
xxxxxxxxxxxxx
$25253509

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
13,074,929Insider8.45%322,297,000
13,053,577Institution8.43%321,770,673
11,842,003Institution7.65%291,905,374
7,614,855Insider4.92%187,706,176
5,524,997Institution3.57%136,191,176
3,767,552Institution2.43%92,870,157
3,066,304Institution1.98%75,584,394
1,498,658Institution0.97%36,941,920
1,466,440Institution0.95%36,147,746
1,419,534Institution0.92%34,991,513

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
11,842,003Institution7.65%291,905,374
3,066,304Institution1.98%75,584,394
1,498,658Institution0.97%36,941,920
1,466,440Institution0.95%36,147,746
1,362,661Institution0.88%33,589,594
1,197,220Institution0.77%29,511,473
815,949Institution0.53%20,113,143
718,814Institution0.46%17,718,765
655,516Institution0.42%16,158,469
557,664Institution0.36%13,746,418

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,717,556Institution2.40%91,637,755
3,573,221Institution2.31%90,331,027
4,301,809Institution2.78%85,003,746
3,513,297Institution2.27%69,422,749
2,060,663Institution1.33%40,718,701
1,952,989Institution1.26%38,591,063
1,236,458Institution0.80%30,478,690
673,958Institution0.44%17,037,658
549,637Institution0.36%10,860,827
490,649Institution0.32%9,695,224

FAQ

Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 30.64% of the company's stock is held by institutional investors, 31.91% is held by insiders, and 19.72% is held by retail investors.
    What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 30.64% of TG Therapeutics (TGTX) stock is held by institutional investors.
      What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 19.72% of TG Therapeutics (TGTX) stock is held by retail investors.
        Who owns the most shares of TG Therapeutics (TGTX)?
        Michael S. Weiss owns the most shares of TG Therapeutics (TGTX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis